Ecology and genetic susceptibility of HCV RNA in various isonym groups of Punjab, Pakistan

Subjects & Methods: A sample of 349 chronic HCV hospital patients was studied who were already taking the treatment of standard therapy of Interferon+Ribavirin thrice a week. The sample was naturally divisible into three groups: Responder, the patients who received the standard therapy and recovered/cured; Relapser, the patients who, after a course of therapy became negative for HCV RNA but after sometimes (6-18 months) became HCV positive again; Non-responder, the patients who did not show positive response to therapy.